Glycogen Synthase Kinase-3 Maleimide Inhibitors As Potential PET-Tracers for Imaging Alzheimer’s Disease: 11C-Synthesis and In Vivo Proof of Concept

Citation
Giglio, J., Fernandez, S., Martinez, A., Zeni, M., Reyes, L., Rey, A., & Cerecetto, H. (2021). Glycogen Synthase Kinase-3 Maleimide Inhibitors As Potential PET-Tracers for Imaging Alzheimer’s Disease: 11C-Synthesis and In Vivo Proof of Concept. Journal of Medicinal Chemistry, 65(2), 1342–1351. https://doi.org/10.1021/acs.jmedchem.1c00769
DOI:
DOI: 10.1021/acs.jmedchem.1c00769
Year of publication:
2022